Zeit | Aktuelle Nachrichten | ||
---|---|---|---|
Do | CPTx Appoints McDavid Stilwell as Chief Financial Officer | ||
Do | BMS Pays Evotec $75M for Molecular Glue Research Progress | ||
Do | Mosaic Therapeutics In-Licenses Oncology Programs from Astex | ||
Do | CN Bio & Pharmaron Partner to Advance Organ-on-a-Chip Drug Discovery | ||
Do | Hansa Biopharma Appoints New CEO | ||
Do | Debiopharm & Oncodesign Partner on Cancer Imaging Tech | ||
Do | Ferring Pharmaceuticals' Drug Product Manufacturing Hub in NJ Approved by FDA | ||
Do | Integer Announces CEO Succession Plan | ||
Do | PCI Pharma Services to Acquire Ajinomoto Althea | ||
Do | EVERSANA Expands Distribution Center with Cold Chain Capabilities and AI-Powered Robotics | ||
Do | Asahi Kasei Taps Ken Shinomiya as Leader of Its Healthcare Sector | ||
Mi | Galapagos Appoints Founding CEO of Newly Created SpinCo | ||
Mi | Repertoire & Genentech Partner on Autoimmune T-Cell Therapies | ||
Mi | Zealand Pharma appoints Utpal Singh as Chief Scientific Officer | ||
Mi | Antag Therapeutics Adds New Leadership | ||
Di | Suanfarma Taps Pere Mañé Godina as CEO | ||
Di | Roche to Invest $50B in the U.S. | ||
Di | Carbogen Amcis Obtains Drug Manufacturing License from Chinese NMPA | ||
Di | Phlow Corp. Expands Analytical Capabilities & Invests in AI | ||
Di | Fujifilm Diosynth Biotechnologies & Regeneron Sign 10-Year U.S. Manufacturing Agreement | ||
Di | Jazz Pharmaceuticals Acquires Chimerix for $935M | ||
Mo | BigHat & Lilly Partner on AI Antibody Discovery | ||
Mo | FDA Approves Dupixent in the U.S. for Chronic Spontaneous Urticaria | ||
Mo | Thermo Fisher Scientific Opens Advanced Therapies Collaboration Center | ||
Mo | Rigaku and Spera Pharma Partner to Accelerate Pharmaceutical Development |